search
Back to results

Rotational Stability of the Acrysof, Tecnis and Envista Intraocular Lenses

Primary Purpose

Cataract, Astigmatism

Status
Completed
Phase
Not Applicable
Locations
Austria
Study Type
Interventional
Intervention
Implantation of an Alcon Acrysof SN60WF intraocular lens
Implantation of an AMO Tecnis ZCB00 intraocular lens
Implantation of an Envista MX60 intraocular lens
Sponsored by
Medical University of Vienna
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cataract

Eligibility Criteria

40 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Uni- or bilateral age-related cataract necessitating phacoemulsification extraction and posterior IOL implantation
  • Need for spherical IOL correction between 10.00 and 30.00 D
  • Pupil dilation of ≥ 6.5 mm
  • Age 40 and older

Exclusion Criteria:

  • Corneal abnormality
  • Pseudoexfoliation
  • Preceding ocular surgery or trauma
  • Uncontrolled glaucoma
  • Proliferative diabetic retinopathy
  • Iris neovascularization
  • History of uveitis/iritis
  • Microphthalmus
  • Recurrent intraocular inflammation of unknown etiology
  • Blind fellow eye
  • Uncontrolled systemic or ocular disease
  • Pregnancy and lactation

Sites / Locations

  • Medical University of Vienna Allgemeines Krankenhaus

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

Acrysof Rotation

Tecnis Rotation

Envista Rotation

Arm Description

Implantation of the Acrysof SN60WF Intraocular lens to the 0 ±10, 45± 10, 90±10 or 135± axis.

Implantation of the Tecnis ZCB00 Intraocular lens to the 0 ±10, 45± 10, 90±10 or 135± axis.

Implantation of the Envista MX60 Intraocular lens to the 0 ±10, 45± 10, 90±10 or 135± axis.

Outcomes

Primary Outcome Measures

Rotational stability from End of Surgery to 6 months
Change in axis position of an intraocular lens Alcon SN60WF, AMO Tecnis ZCB00 or Bausch&Lomb Envista MX60 from end of surgery (baseline axis) to 1 hour, 1 week, 1 month and 4-7 months (end of study visit). The change in axis position will be evaluated with respect to the baseline measurement at the end of surgery. Differences in axis position will be described as rotation in degrees (0 to 360°)

Secondary Outcome Measures

Decentration
Decentration of the intraocular lens Alcon SN60WF, AMO Tecnis ZCB00 or Bausch&Lomb Envista MX60 will be measured with a Purkinje Meter. Decentration will be described as "Decentration in milimeter"
Tilt
Tilt of the intraocular lens Alcon SN60WF, AMO Tecnis ZCB00 or Bausch&Lomb Envista MX60 will be measured with a Purkionje Meter. Tilt will be described as "Tilt in degrees at a certain axis"

Full Information

First Posted
April 8, 2020
Last Updated
April 10, 2020
Sponsor
Medical University of Vienna
search

1. Study Identification

Unique Protocol Identification Number
NCT04345380
Brief Title
Rotational Stability of the Acrysof, Tecnis and Envista Intraocular Lenses
Official Title
Rotational Stability of the Acrysof, Tecnis and Envista Intraocular Lenses
Study Type
Interventional

2. Study Status

Record Verification Date
April 2020
Overall Recruitment Status
Completed
Study Start Date
June 9, 2015 (Actual)
Primary Completion Date
August 18, 2017 (Actual)
Study Completion Date
August 18, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical University of Vienna

4. Oversight

5. Study Description

Brief Summary
Brief Summary: Age-related cataract is the main cause of impaired vision in the elderly population worldwide. In the UK, more than half of people who are over 65 years old have some cataract development in one or both eyes. The only treatment that can restore functional visual ability is cataract surgery where the opacified crystalline lens is removed by phacoemulsification and an artificial intraocular lens is implanted. It is estimated that around 10 million cataract operations are performed around the world each year. Cataract operations are generally very successful, with a low risk of serious complications. During the past two decades, cataract surgery underwent tremendous change and modernisation resulting in today's small incision phacoemulsification surgery and a safe technique with a short rehabilitation time for the patient. Traditional spherical monofocal intraocular lenses (IOLs) restore best-corrected vision and may lessen the need for spectacles. These IOLs correct only the spherical portion of the total refractive error and do not correct corneal astigmatism. Astigmatism is a visually disabling refractive error affecting the general population, especially those with cataract. At least 15% to 20% of cataract patients have 1.5 diopters (D) or more of corneal or refractive astigmatism. With increased patient expectations, the trend is not only to remove the cataract but also to address the problem of pre-existing astigmatism at the time of surgery. Surgical-induced astigmatism can be reduced by smaller incisions, i.e. microincision cataract surgery (MICS), which by definition is surgery performed through incisions smaller than 2.0 mm, reducing the need for suturing. This results in better corneal optical quality, thus improving visual outcomes. There are also other surgical options to correct preexisting astigmatism during cataract surgery like: selectively positioning of the phacoemulsification incision; astigmatic keratotomy with corneal or limbal relaxing incisions; excimer laser refractive procedures such as photorefractive keratectomy, laser in situ keratomileusis, and laser-assisted subepithelial keratectomy; or implanting pseudophakic toric posterior chamber intraocular lenses (IOLs). Toric IOLs have been shown to result in good visual and refractive outcomes. Combined with MICS, these IOLs can allow effective correction of cylindrical errors intraoperatively, improving visual quality and thus leading to spectacle independence. Plate haptic and loop haptic toric IOLs have been considered for about a decade but have been associated with postoperative rotational instability. Rotation of a toric lens from its intended orientation degrades its corrective power, with approximately 3.3% loss of cylindrical power for every degree off axis. A misorientation of approximately 30° negates the effectiveness of astigmatic correction, and a misorientation of more than 30° may induce additional astigmatism. Although some patients are asymptomatic despite induced astigmatism, others experience symptoms such as blurred or distorted vision, headache, fatigue, eyestrain, squinting, or eye discomfort. Thus, IOL orientation stability is an essential goal in toric IOL design. RATIONALE The purpose of this study is to assess and compare the axial IOL rotation and optical quality (refraction, visual acuity, decentration and tilt) and capsular bag reaction after micro-incision surgery with an IOL implantation in cataract patients - Acrysof SN60WF, Tecnis ZCB00 & Envista MX60 IOL

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cataract, Astigmatism

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
199 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Acrysof Rotation
Arm Type
Active Comparator
Arm Description
Implantation of the Acrysof SN60WF Intraocular lens to the 0 ±10, 45± 10, 90±10 or 135± axis.
Arm Title
Tecnis Rotation
Arm Type
Active Comparator
Arm Description
Implantation of the Tecnis ZCB00 Intraocular lens to the 0 ±10, 45± 10, 90±10 or 135± axis.
Arm Title
Envista Rotation
Arm Type
Active Comparator
Arm Description
Implantation of the Envista MX60 Intraocular lens to the 0 ±10, 45± 10, 90±10 or 135± axis.
Intervention Type
Other
Intervention Name(s)
Implantation of an Alcon Acrysof SN60WF intraocular lens
Intervention Description
Patients suffering from senile cataract getting replaced their human crystalline cataractous lens
Intervention Type
Other
Intervention Name(s)
Implantation of an AMO Tecnis ZCB00 intraocular lens
Intervention Description
Patients suffering from senile cataract getting replaced their human crystalline cataractous lens
Intervention Type
Other
Intervention Name(s)
Implantation of an Envista MX60 intraocular lens
Intervention Description
Patients suffering from senile cataract getting replaced their human crystalline cataractous lens
Primary Outcome Measure Information:
Title
Rotational stability from End of Surgery to 6 months
Description
Change in axis position of an intraocular lens Alcon SN60WF, AMO Tecnis ZCB00 or Bausch&Lomb Envista MX60 from end of surgery (baseline axis) to 1 hour, 1 week, 1 month and 4-7 months (end of study visit). The change in axis position will be evaluated with respect to the baseline measurement at the end of surgery. Differences in axis position will be described as rotation in degrees (0 to 360°)
Time Frame
4-7 months
Secondary Outcome Measure Information:
Title
Decentration
Description
Decentration of the intraocular lens Alcon SN60WF, AMO Tecnis ZCB00 or Bausch&Lomb Envista MX60 will be measured with a Purkinje Meter. Decentration will be described as "Decentration in milimeter"
Time Frame
4 to 7 months
Title
Tilt
Description
Tilt of the intraocular lens Alcon SN60WF, AMO Tecnis ZCB00 or Bausch&Lomb Envista MX60 will be measured with a Purkionje Meter. Tilt will be described as "Tilt in degrees at a certain axis"
Time Frame
4 to 7 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Uni- or bilateral age-related cataract necessitating phacoemulsification extraction and posterior IOL implantation Need for spherical IOL correction between 10.00 and 30.00 D Pupil dilation of ≥ 6.5 mm Age 40 and older Exclusion Criteria: Corneal abnormality Pseudoexfoliation Preceding ocular surgery or trauma Uncontrolled glaucoma Proliferative diabetic retinopathy Iris neovascularization History of uveitis/iritis Microphthalmus Recurrent intraocular inflammation of unknown etiology Blind fellow eye Uncontrolled systemic or ocular disease Pregnancy and lactation
Facility Information:
Facility Name
Medical University of Vienna Allgemeines Krankenhaus
City
Vienna
ZIP/Postal Code
1090
Country
Austria

12. IPD Sharing Statement

Learn more about this trial

Rotational Stability of the Acrysof, Tecnis and Envista Intraocular Lenses

We'll reach out to this number within 24 hrs